O
Olin Corporation
OLN · Basic Materials
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
A Cheap Cyclical Where the Cheapness Is Partly Borrowed From the Future
The market is pricing Olin as a beaten-down cyclical awaiting a spread recovery, but is largely ignoring that capex running at forty cents per depreciation dollar means the reported FCF — the very metric making the stock look cheap — is a partial fiction built on deferred maintenance that will eventually demand repayment.
Flowly Score
Apr 16 Close
+72%$27.98
Fair Value
$48.00
33
Weakat $27.98
Business Strength4/10
Winchester is a genuine brand moat in a sea of commodity chemistry — but one durable segment cannot rescue a portfolio where the core chlor-alkali business has essentially no pricing power through the trough, and the epoxy franchise has been structurally surrendered to Chinese producers. The ROIC collapse from supercycle highs to near-zero in under three years is the honest answer about what this business actually earns through a full cycle.
Financial Resilience4/10
Cash conversion is genuinely strong — posting nearly half a billion in operating cash in a GAAP loss year is real resilience, not accounting theater. But the Altman Z sitting just below the gray zone while capex runs at roughly forty cents per dollar of depreciation is a dangerous combination: financial stress signals appearing at the exact moment the company is harvesting its asset base to manufacture the cash that masks that stress.
Growth & Trajectory3/10
Management guided Q1 2026 below an already-dismal Q4 2025, and the structural force behind the revenue and margin collapse — Chinese chlorine-derivative exports growing three-to-sixfold since 2019 — does not reverse on a quarterly schedule. The Beyond $250 cost program is real execution, but it's a scalpel applied to a wound that requires a market cycle to close.
Valuation6/10at $23.80
Even the pessimistic DCF scenario implies meaningful upside from today's price, and a sub-one-times sales multiple on a business with real infrastructure and a durable ammunition franchise captures significant pessimism. The important caveat is that reported FCF is partly harvested from future maintenance obligations, so the true margin of safety is thinner than the headline metrics suggest — fair value is closer to the pessimistic scenario than the midpoint.
Risk3/10
The risk bucket is genuinely crowded: credit risk embedded in the Z-Score, economic value destruction with ROIC below WACC, structural Chinese overcapacity with no near-term resolution, a leadership transition at cycle trough, and an asset base being systematically underinvested at the worst possible moment. Any one of these in isolation is manageable; all five arriving simultaneously is a different situation entirely.
The investment case for Olin is seductive in the way all deep-trough cyclicals are: a sub-one-times sales multiple, a double-digit FCF yield, and a pessimistic DCF that still implies material upside. Winchester, the ammunition franchise, is a genuinely durable business with brand pricing power that the market bundles in as an afterthought. And the chlor-alkali infrastructure, while cyclically devastated, has real replacement cost value that the current market cap does not fully reflect. The problem is that quality and price interact badly here — the business generating the apparent cheapness has no structural earnings power at trough, and the FCF that anchors the valuation case is partly a loan against future asset integrity. The trajectory from here is unlikely to be a V-shape. Chinese export volumes of chlorine derivatives have compounded at a rate that took years to build and will take years to absorb — there is no demand catalyst large enough to overwhelm that supply overhang in the near term. The cost savings program is genuine industrial execution, and the Stade supply contract fix for epoxy is a real improvement, but neither moves the needle on the spread economics that determine eighty percent of earnings power. Q1 2026 is expected to be worse than Q4 2025. The electrolyzer disruption risk to the co-product model is a decade away, but the Chinese overcapacity problem is right now. The single biggest specific risk is the capex-depreciation gap colliding with the Altman Z-Score. Olin is spending far less than depreciation to maintain its asset base while simultaneously showing financial stress signals — the two trends reinforce each other right up until the moment plant reliability forces full maintenance spending to resume. When that happens alongside still-compressed chlor-alkali spreads, the cash generation that keeps the balance sheet stable disappears at precisely the moment the debt load is most burdensome. That scenario, not a Chinese capacity wave, is the path to genuine distress.